At 11:25 AM -0500 1/21/99, [EMAIL PROTECTED] wrote:
>Zyprexa (olanzapine),one of the newest (released October 1996) atypical
>antipsychotics is made by Eli Lilly, Indianapolis, Indiana. If you call or
>write them they will send a very nice packet of information for professionals
>in the mental health field. Basically, it spares the D2 receptors which are
>implicated in the major muscular problems inherent with haldol. Furthermore,
>it does not cause the problems with agranulocytosis that closapine does, nor
>does it seem to produce the copious drooling which so many patients on
>closapine have to cope with. There are several new antipsychotics out now as
>later generations to closapine, one of which is Sertindol by Abbot labs who
>will also send info. There are a few more but I don't have my info with me
>right now and can't think of their names. Because olanzapine is new, clinical
>trials are still being done to assess longer term potential S/Es.
>
>Hope this helps,
>Lynn Sproul, RN
Or, you could read Eliot Valenstein's new book (Blaming the Brain: the
Truth About Drugs and Mental Health, 1998) for a well-documented critical
opinion about the drug industry and the effectiveness of psychoactive
medications. There's a long history of new drugs introduced which
supposedly have fewer undesirable side effects that existing drugs (e.g.,
heroin as a less-addictive alternative to morphine).
I'd recommend supplementing Lilly's info with a MedLine search.
* PAUL K. BRANDON [EMAIL PROTECTED] *
* Psychology Department 507-389-6217 *
* "The University formerly known as Mankato State" *
* http://www.mankato.msus.edu/dept/psych/welcome.html *
